Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast Growth Factors”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Testing effectiveness (Phase 2)UnknownNCT05775874
What this trial is testing

Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC

Who this might be right for
Urothelial Carcinoma
Abbisko Therapeutics Co, Ltd 80
Post-approval studies (Phase 4)UnknownNCT04419363
What this trial is testing

Burosumab in Children and Adolescents With X-linked Hypophosphatemia

Who this might be right for
Rare DiseasesX-linked Hypophosphatemia
Bicetre Hospital 57
Testing effectiveness (Phase 2)Ended earlyNCT01066871
What this trial is testing

Sprifermin (AS902330) in Cartilage Injury Repair (CIR)

Who this might be right for
Isolated Cartilage Injury of the Knee
Merck KGaA, Darmstadt, Germany 74
Not applicableLooking for participantsNCT04752293
What this trial is testing

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Who this might be right for
HypertensionLeft Ventricular HypertrophyLeft Ventricular Dysfunction+15 more
Wake Forest University Health Sciences 125
Testing effectiveness (Phase 2)Study completedNCT03011372
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 47
Not applicableStudy completedNCT00694824
What this trial is testing

Vascular Calcification's Risk Factors in Haemodialysis Patients

Who this might be right for
Chronic Kidney FailureInflammationVascular Calcification
IRCCS Azienda Ospedaliero-Universitaria di Bologna 253
Testing effectiveness (Phase 2)Looking for participantsNCT07169279
What this trial is testing

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 77
Not applicableStudy completedNCT03106298
What this trial is testing

Iron Deficiency and FGF23 Regulation in CKD and HF

Who this might be right for
Chronic Kidney DiseasesChronic Heart FailureIron Deficiency Anemia
Northwestern University 77
Not applicableNot Yet RecruitingNCT06842810
What this trial is testing

Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erthematosus
Assiut University 95
Testing effectiveness (Phase 2)Study completedNCT01752920
What this trial is testing

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Who this might be right for
Solid Tumor
Basilea Pharmaceutica 119
Not applicableTemporarily pausedNCT03193073
What this trial is testing

Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

Who this might be right for
Anemia of Chronic Kidney DiseaseEndothelial DysfunctionLeft Ventricular Hypertrophy+1 more
Omnia Mohammed Hashem 80
Not applicableStudy completedNCT04012983
What this trial is testing

Possible Role of Gingival Crevicular Fluid Levels of Chemerin and Fibroblast Growth Factor 21 as Biomarkers of Periodontal Disease in Diabetic and Non-diabetic Patients

Who this might be right for
Periodontal Disease (Diagnosis)Diabetes Mellitus, Type 2
Cairo University 45
Not applicableLooking for participantsNCT06201533
What this trial is testing

Low-intensity Physical-cognitive Exercise and Cognitive Function

Who this might be right for
Mild Cognitive Impairment
Chiang Mai University 64
Large-scale testing (Phase 3)Study completedNCT05052801
What this trial is testing

Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 547
Early research (Phase 1)WithdrawnNCT04972253
What this trial is testing

Phase I BLASST-3 Trial

Who this might be right for
Bladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor
Guru P. Sonpavde
Not applicableStudy completedNCT00066183
What this trial is testing

Studying Phosphorus Metabolism

Who this might be right for
Phosphorus Metabolism
National Institute of Dental and Craniofacial Research (NIDCR) 100
Large-scale testing (Phase 3)Ended earlyNCT03773302
What this trial is testing

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

Who this might be right for
Advanced CholangiocarcinomaFGFR2 Gene Mutation
QED Therapeutics, a BridgeBio company 48
Not applicableStudy completedNCT02062307
What this trial is testing

Bone Mineral Markers in Hypogonadism

Who this might be right for
Hypogonadotropic HypogonadismEndothelial DysfunctionInsulin Resistance
Gulhane School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT04045613
What this trial is testing

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Basilea Pharmaceutica 95
Testing effectiveness (Phase 2)Study completedNCT06806319
What this trial is testing

Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening

Who this might be right for
Gingival Overgrowth
Al-Azhar University 80
Next Page